Autres langues GlaxoSmithKline S.A.E

Actions

BIOC

EGS38171C012

Cours en clôture Egyptian Exchange Autres places de cotation 00:00:00 24/04/2024			Varia. 5j.	Varia. 1 janv.
32,32 ^EGP	+2,41 %		-0,15 %	-9,09 %

04/03	GlaxoSmithKline S.A.E. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	GlaxoSmithKline S.A.E. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	04/03
GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/11
GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/08/23
GlaxoSmithKline S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023	31/05/23
GlaxoSmithKline S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2022	14/06/22
GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2021	30/05/22
GlaxoSmithKline E : Glaxo Smith Kline (BIOC.CA) - Listing Committee Decision	10/03/22
GSK hires former Tesco boss Sir Dave Lewis to head up £40bn spin-off	20/12/21
GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
GlaxoSmithKline S.A.E Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021	12/08/21
Glaxosmithkline S.A.E Reports Standalone and Consolidated Financial Results for the Quarter Ended March 31, 2021	16/06/21
Glaxosmithkline S.A.E Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2020	01/04/21
Hikma Pharmaceuticals PLC cancelled the acquisition of GlaxoSmithKline S.A.E.	11/03/21
Glaxo Group Receives Letter from ACDIMA for Acquisition of Glaxosmithkline Shares	01/02/21
Hikma Pharmaceuticals PLC entered into a non-binding term sheet to acquire 91.2% stake in GlaxoSmithKline S.A.E from Glaxo Group Limited.	26/01/21
GlaxoSmithKline S.A.E Reports Audited Standalone Earnings Results for the Year Ended December 31, 2019	01/05/20
GSK Egypt to Launch 2 Production Lines with EGP 100 million Investments	21/11/19
Glaxo Smith Kline Announces Consolidated Earning Results for the Nine Months Ended September 30, 2018	22/09/19
GlaxoSmithKline S.A.E Announces Consolidated and Standalone Earnings Results for the First Quarter Ended March 31, 2018	27/11/18
GlaxoSmithKline S.A.E Announces Consolidated and Standalone Earnings Results for the Six Months Ended June 30, 2018	27/11/18

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GlaxoSmithKline S.A.E

Actions

BIOC

EGS38171C012

Autres langues

Filtres